Results 91 to 100 of about 346 (125)

Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews. [PDF]

Clin Exp Med, 2023
Pecoraro V, Pirotti T, Trenti T.
europepmc   +1 more source

Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. [PDF]

Virol J, 2021
Lai A, Bergna A, Menzo S, Zehender G, Caucci S, Ghisetti V, Rizzo F, Maggi F, Cerutti F, Giurato G, Weisz A, Turchi C, Bruzzone B, Ceccherini Silberstein F, Clementi N, Callegaro A, Sagradi F, Francisci D, Venanzi Rullo E, Vicenti I, Clementi M, Galli M, collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise.   +22 more
europepmc   +1 more source

Efficacy and Safety of Sotrovimab Versus Oral Antiviral for Early Treatment in High-Risk Patients in Omicron Era: A Multicenter Retrospective Study. [PDF]

Pathogens
Russo A, Pisaturo M, Cacace C, Troise A, Granata G, Grimaldi P, Allegorico E, Ambrisi F, Papillo M, Numis FG, Coppola N.   +10 more
europepmc   +1 more source

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.

JAMA Netw Open, 2023
Januel E, Hajage D, Labauge P, Maillart E, De Sèze J, Zephir H, Pelletier J, Guilloton L, Bensa C, Heinzlef O, Casez O, Biotti D, Bourre B, Vukusic S, Maurousset A, Berger E, Laplaud D, Lebrun-Frénay C, Dubessy AL, Branger P, Thouvenot E, Clavelou P, Sellal F, Manchon E, Moreau T, Papeix C, Tubach F, Louapre C.   +27 more
europepmc   +1 more source

Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort. [PDF]

Infection
Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I, Sangiovanni V, Rossomando A, Pacilio R, Calabria G, Pisapia R, Carriero C, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N, CoviCam group.   +21 more
europepmc   +1 more source

Molecular and epigenetic markers as promising tools to quantify the effect of occupational exposures and the risk of developing non-communicable diseases. [PDF]

Med Lav, 2019
Ferrari L, Pavanello S, Bollati V.
europepmc   +1 more source

[Molecular genetic testing according to the latest European guidelines on hypertrophic cardiomyopathy]. [PDF]

G Ital Cardiol (Rome), 2015
Brun F, Mestroni L, Sinagra G.
europepmc   +1 more source

Somatic mutations in the TG and RELA genes specific for radioiodine-refractory thyroid cancer. [PDF]

Sci Rep
Sukprakun C, Nuwongsri P, Tongkobpetch S, Srichomthong C, Vinayanuwattikun C, Keelawat S, Jantasuwan S, Tangjaturonrasme N, Samorn P, Shotelersuk V, Tepmongkol S.   +10 more
europepmc   +1 more source

Analisi di costo-efficacia di nirmatrelvir/ritonavir in pazienti adulti ad alto rischio di progressione a COVID-19 severo. [PDF]

Glob Reg Health Technol Assess
Moreno C, Aiello A, Di Virgilio R, Mazzotta V, Antinori A.   +4 more
europepmc   +1 more source

[Health Technology Assessment of meningococcal B vaccine (Trumenba^®) in adolescent in Italy]. [PDF]

J Prev Med Hyg, 2019
Boccalini S, Bechini A, Sartor G, Paolini D, Innocenti M, Bonanni P, Panatto D, Lai PL, Zangrillo F, Marchini F, Lecini E, Iovine M, Amicizia D, Landa P.   +13 more
europepmc   +1 more source